Latest news
Death of law student linked to popular weight loss shot - AL.comAL.com · Mon, 10 Aug 2026 13:13:00 GMTSudden death of California law student studying abroad linked to popular weight loss shot, inquest heard - New York PostNew York Post · Mon, 10 Aug 2026 02:35:00 GMTPfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound - The Motley FoolThe Motley Fool · Fri, 07 Aug 2026 20:28:00 GMTExpanding Access to Weight-Loss Medications: The Medicare GLP-1 Bridge Program - The National Council on Aging (NCOA)The National Council on Aging (NCOA) · Fri, 07 Aug 2026 04:00:00 GMTLilly, Novo defeat antitrust lawsuit over GLP‑1 drug market - ReutersReuters · Thu, 06 Aug 2026 21:52:51 GMTAmazon Pharmacy now delivers GLP-1 medications to eligible Medicare patients for $50 a month - About AmazonAbout Amazon · Thu, 06 Aug 2026 10:07:15 GMTWhy Is Eli Lilly Stock Gaining Wednesday? - Eli Lilly (NYSE:LLY) - BenzingaBenzinga · Wed, 05 Aug 2026 16:06:02 GMTHow To Get Zepbound: Eligibility Criteria And Where To Buy - ForbesForbes · Mon, 03 Aug 2026 18:36:00 GMT